These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37335211)

  • 1. Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers: A Pilot, Proof-of-Concept, Feasibility, Randomized-Controlled Trial.
    Rossi GN; Rocha JM; Osório FL; Bouso JC; Ona G; Silveira GO; Yonamine M; Bertozi G; Crevelin EJ; Queiroz ME; Crippa JAS; Hallak JEC; Dos Santos RG
    J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):339-349. PubMed ID: 37335211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.
    Rocha JM; Rossi GN; de Lima Osório F; Bouso JC; de Oliveira Silveira G; Yonamine M; Campos AC; Bertozi G; Cecílio Hallak JE; Dos Santos RG
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):267-274. PubMed ID: 33843820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial.
    Dos Santos RG; Osório FL; Rocha JM; Rossi GN; Bouso JC; Rodrigues LS; de Oliveira Silveira G; Yonamine M; Hallak JEC
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):540-550. PubMed ID: 34166299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trials.
    Dos Santos RG; Rocha JM; Rossi GN; Osório FL; Ona G; Bouso JC; Silveira GO; Yonamine M; Marchioni C; Crevelin EJ; Queiroz ME; Crippa JA; Hallak JEC
    Hum Psychopharmacol; 2022 Jul; 37(4):e2834. PubMed ID: 35107855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
    Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R
    JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use: A Single-blind, Feasibility, Proof-of-Concept Trial.
    Rodrigues LS; Reis JAS; Rossi GN; Guerra LTL; Maekawa RM; de Lima Osório F; Bouso JC; Santos FP; Paranhos BAPB; Yonamine M; Hallak JEC; Dos Santos RG
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):402-406. PubMed ID: 38820373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of Cannabidiol (CBD) and Delta-9-Tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: A systematic review of randomized controlled trials.
    Rossi GN; Osório FL; Morgan CJA; Crippa JAS; Bouso JC; Rocha JM; Zuardi AW; Hallak JEC; Santos RGD
    Neurosci Biobehav Rev; 2020 Nov; 118():236-246. PubMed ID: 32745478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.
    Mendes Rocha J; Rossi GN; Osório FL; Bouso Saiz JC; Silveira GO; Yonamine M; Crevelin EJ; Queiroz ME; Cecílio Hallak JE; Dos Santos RG
    Front Psychiatry; 2021; 12():688439. PubMed ID: 34421675
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).
    Mersiades AJ; Tognela A; Haber PS; Stockler M; Lintzeris N; Simes J; McGregor I; Olver I; Allsop DJ; Gedye C; Kirby AC; Morton RL; Fox P; Clarke S; Briscoe K; Aghmesheh M; Wong N; Walsh A; Hahn C; Grimison P
    BMJ Open; 2018 Sep; 8(9):e020745. PubMed ID: 30209152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
    Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
    Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
    Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.
    Rocha JM; Osório FL; Crippa JAS; Bouso JC; Rossi GN; Hallak JEC; Dos Santos RG
    Ther Adv Psychopharmacol; 2019; 9():2045125319845774. PubMed ID: 31065350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
    Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
    Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
    Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
    Riba J; Anderer P; Morte A; Urbano G; Jané F; Saletu B; Barbanoj MJ
    Br J Clin Pharmacol; 2002 Jun; 53(6):613-28. PubMed ID: 12047486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study.
    Sanches RF; de Lima Osório F; Dos Santos RG; Macedo LR; Maia-de-Oliveira JP; Wichert-Ana L; de Araujo DB; Riba J; Crippa JA; Hallak JE
    J Clin Psychopharmacol; 2016 Feb; 36(1):77-81. PubMed ID: 26650973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
    Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
    JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
    Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
    Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.